You can't ask for better management.

I see a very bright future in RTON

Just a note to say hello to an old time friend Jerry G. Wishing you well. Howie Haftel

Taronis Fuels Releases 2019 Results of OperationsPress Release | 05/18/2020

118% Annual Revenue Growth,

Record Fourth Quarter EBITDA Improvement

PHOENIX, AZ, May 18, 2020 (GLOBE NEWSWIRE) -- Taronis Fuels, Inc., (“Taronis” or “the Company”) (OTCQB: TRNF), a global producer of renewable and socially responsible fuel products, today released results of operations for the full year ending December 31, 2019. The Company achieved a series of significant financial milestones in 2019, which are summarized below:

Revenues were a record $21.1 million, representing a 118% increase from $9.7 million the prior year. Sales increased across all of the Company’s US retail operations.
The Company acquired nine locations in 2018 through six acquisitions. Same store sales for these nine locations increased by 82% year over year in 2019. This demonstrates a strong validation of the Company’s operational execution and a clear ability to drive growth without a reliance on acquisitions.
Gross margins improved dramatically to 51% in 2019, as compared to approximately 42% in 2018. The increase was partly due to major improvements in buying power, as well as a shift towards a more profitable product mix, including the impact of increased sales of MagneGas as a growing contribution to total sales.
Operating expenses were $15.7 million, as compared to $8.7 million in 2018. However, expenses significantly decreased as a percentage of total sales, decreasing from 89.7% in 2018 to only 74% in 2019.
The Company reduced its quarterly net loss by 56%, from $2.1 million in the third quarter of 2019 to $0.9 million in the fourth quarter.
Working capital remained consistently positive and strong, with a current ratio of 1.62x.
Excluding a limited number of capital leases and a $0.5 million mortgage on one property, the Company has no material indebtedness and is entirely equity financed.
The Company has more than $4.5 million in cash, with sufficient liquidity to support its current business objectives for the remainder of 2020.

Beyond these financial results, the Company was very active on multiple fronts for both domestic and international business development. The Company completed three acquisitions in the first quarter of 2019, expanding to become a top five independent industrial gas competitor in both California and Texas. All three of these transactions helped to support our growing national retail brand, MagneGas Welding Supply.

The Company was also extremely active overseas, executing a scalable contract for the deployment of an initial 30 gasification units in Turkey for $165 million in July 2019. The Company executed a $250 million marketing agreement that covers 13 countries in central Asia in December 2019. Both of these contracts have progressed materially in 2020. Lastly, the Company secured approval from the Port Authority of Amsterdam and executed a 10-year lease for that port in September 2019, which is expected to be operational in September 2020.

The Company also made significant inroads for additional international expansion throughout the year. Most notably, the Company made meaningful progress in Bahrain, the United Arab Emirates, and El Salvador towards launching partnerships and marketing arrangements to sell MagneGas or other new renewable fuel products to these markets in 2020 and beyond.

“We are very proud of the financial results of operations we produced for 2019,” commented Scott Mahoney, CEO of Taronis. “The rapid revenue growth we delivered in 2019 was likely to be the highest level of sales growth in our industry. We capitalized on a series of international expansion opportunities in Europe and Asia, and we laid the foundation to enter many new markets for years to come.”

“Most importantly, we demonstrated a clear path to sustainable and profitable self-funded growth with our strong financial performance in the fourth quarter. We made tremendous progress, and this has positioned us well to deliver further financial improvements in 2020,” concluded Mr. Mahoney.

TRNF Security Details
Share Structure
Market Cap Market Cap
17,319,412
05/26/2020
Authorized Shares
1,000,000,000
02/26/2020
Outstanding Shares
143,729,561
03/04/2020
Restricted
34,871,291
03/04/2020
Unrestricted
108,858,270
03/04/2020
Held at DTC
Not Available
Float
105,488,280
02/28/2020
Par Value
No Par Value
Market Value calculated only for respective security

Sun Kissed Expands Hakuna Affiliate Marketing Program to Include Numuni Installations
May 27 2020 - 05:30AM

Sun Kissed Expands Hakuna Affiliate Marketing Program to Include Numuni Installations

NEW YORK, NY -- May 27th, 2020 -- InvestorsHub NewsWire -- Sun Kissed Industries Inc. (OTC PINK: SKDI) (“Sun Kissed”, “SKDI”), an emerging leader in the development and sale of CBD consumables, digital content management and online ad monetization technology, today announced the expansion of Hakuna’s affiliate marketing program to now include Numuni client installations.

The Online Advertising Market was valued at $304.0 billion in 2019 and is expected to reach $982.82 billion by 2025, at a CAGR of 21.6% over the forecast period 2020 – 2025 (Source: Mordor Intelligence). This will push digital ad spending to equal, if not surpass for the 1st time, half of global ad spending.

The Numuni platform monetizes the affiliate marketing teams efforts while providing the consumer (client install) the benefits of exclusive access to a partner's media platform in exchange for their unused computational power. This exclusive access may include 'ad-free' viewing, member only website sections, in-game specials and more, dependent on the particular partner platform.

Check out the Numuni (pronounced 'New Money') video on YouTube:

Taronis Fuels Completes Largest Acquisition in Company HistoryPress Release | 05/27/2020

US Operations Cash Flow Positive

PHOENIX, AZ, May 27, 2020 (GLOBE NEWSWIRE) -- Taronis Fuels, Inc., (“Taronis” or “the Company”) (OTCQB: TRNF), a global producer of renewable and socially responsible fuel products, today announced the closing of an $8 million acquisition of one of the largest independent specialty industrial gas distributors in the United States today. The target will be branded TGS, operating as a wholly-owned subsidiary of Taronis Fuels going forward.

TGS’s operations cover the Georgia, Florida and Texas markets, with a dominant market share in the Atlanta, Orlando, Tampa, and Dallas metropolitan markets, and a strong market presence across much of Georgia, north and central Florida, and central and east Texas. TGS is a specialty gas supplier dedicated to the heating, ventilation and air conditioning (“HVAC”) market. The $8 million purchase was structured as $4 million in cash due at closing, and $4 million in multi-year seller debt financing. No equity was issued in conjunction with this transaction.

The TGS acquisition has an immediate, significantly positive financial impact on the Company’s overall financial outlook. TGS generated $8 million in revenues in 2019 and is experiencing rapid growth due to the increased work-from-home policies implemented during the COVID-19 pandemic. So far in 2020, TGS has achieved a record March, record April, and is on pace for record monthly sales results in May. This acquisition brings in approximately $300,000 in added monthly EBITDA, which is projected to grow throughout the remainder of 2020.

With this acquisition, Taronis is now able to generate positive EBITDA cash flows across its combined US operations. The Company is expected to periodically make discretionary investments in international business development, strategic manufacturing capabilities and research and development that may at times produce a short term period of negative EBITDA in order to accelerate growth opportunities and advance certain technology breakthroughs.

“This transaction has the potential to transform our US retail growth model,” commented Scott Mahoney, CEO of Taronis. “We have now added a very unique and compelling growth catalyst into our overall US portfolio. Through this acquisition, we can now enter entirely new markets for a very limited capital investment, and quickly become profitable in these new locations using high-margin HVAC centric gas sales to fund organic growth. This is a powerful benefit as we look to significantly expand our retail network for MagneGas Welding Supply across the United States.”

“There are also several compelling synergies regarding this transaction that offer tremendous organic growth potential across the combined companies. First, we can bring TGS’s HVAC centric sales model into our existing operations across all of California for very little capital investment. This has the potential to add several million dollars in new industrial gas sales on an annualized basis to Taronis Fuels before the end of 2020.”

“Next, we will look to utilize our combined operations to launch new MagneGas Welding Supply retail locations in Atlanta, Orlando, Jacksonville, Miami, Dallas and Houston. We see significant potential for growth as we leverage the collective management team to drive increases to revenue across the integrated business model.”

“We have also mapped out a timeline for expansion into the US southwest, particularly the Las Vegas, Phoenix, Tucson and Denver markets. Longer term, we plan to expand into Oklahoma City, New Orleans, Charlotte, Nashville and Memphis in 2021 and beyond.”

“Lastly, and most importantly, we made this acquisition because the primary industrial gas product sold within the HVAC industry is acetylene. It is the dominant metal cutting fuel in a massive and recession proof industry. In fact, more than one third of the target’s revenues are derived from acetylene sales, and our team is excited to begin transitioning those clients to MagneGas, the only renewable metal cutting fuel product on the market today,” concluded Mr. Mahoney.

We are a renewable fuel and power generation company. Our primary business objective is the production of sustainable, socially responsible alternatives to existing fossil fuel and industrial gas products. Our first commercially competitive product is a metal cutting fuel called "MagneGas". MagneGas is a proprietary synthetic gas comprised primarily of hydrogen that is produced by the Company from its Venturi Flow Submerged Plasma Arc Gasification Units ("Gasification Units"). We sell MagneGas, Gasification Units, other specialty gases and ancillary products globally.

The company has the best product available and now they are hooking up with marketing and distributors.

In the past there have been many fires and explosions with many deaths. This new magnagas is the answer.

This company is a spin off from TRNX, run by the same management but left to do its own thing.

This is a company everybody has been waiting for. A gas that is safe to use.

Cytodyn, Inc is not a threat to big pharma till the FDA approves the drug. Once that happens then all hell will break loose.

Big Pharma must protect their revenue base. To do that they have to get control of the company.

There will be either a buy out or some sort of a joint venture.

It will be good for both parties. Unlimited cash to operate world wide. Exposure to the market from big pharma can't be met by Cytodyn for many years to come. Its a win / win for both parties.

In just a few hours from now we should hear something from the company, Good or Bad, I don't have a clue.

The possibilities are enormous and the general opinion is the news will be positive.

What ever the case we know their drug can be used to fight Cancer, Hiv and now the Corona Virus.

There are a lot of IFS involved. The Big one is the FDA approving the use.

The main goal is to save lives and the longer we wait for approval the more lives will be lost.

Lets all hope the news coming is positive.

If I were to have a choice on a buy out I would pick Gilead. The major threat is against them and so to eliminate the threat you take them over.

The best and most logical thing Big Pharma can do to maintain their dominance in the drug industry is simply buy out Cytodyn,(CYDY). They have the money and that would guarantee control.

THANK YOU ALL FOR YOUR GOOD WISHES.

I remember very little and all I can say I was in special ops. I have memory disease. This all happened some 65 years ago.

Good Morning America!

I am an ex Korean War Vet.

This is a day to relax and honor our buddies that have past supporting the freedom of all American citizens. Fly the flag with pride and never forget the people that gave up their lives so we could all live free.

Good Morning America!

I am an ex Korean War Vet.

This is a day to relax and honor our buddies that have past supporting the freedom of all American citizens. Fly the flag with pride and never forget the people that gave up their lives so we could all live free.

Talk about potential. It appears that this company has a drug, {LERONLIMAB}, That can be used for just about every major disease.

Sure time will tell if this is so but if the drug can help with just one disease well then its a $500 stock long term.

You have to be nuts not to pick up a few shares.

My compensation will be in the success of RMHB. The lies continue to fly by the shorts to improve their positions. Believe what you will, only time will tell.

My reward will follow the success of RMHB in Mexico and California. I don't have to bash to keep my short profitable. All you shorts have to make up lies to keep ahead of the game. You will find that will stop very soon. My advise is to cover your short position and go long other wise you will get a rude awakening very soon.

Don't be fooled by RMHB being quiet. They have been working hard to grow the company. The two main fronts are Mexico and California. New product lines are being introduced and the response has been very positive. If you are short this stock you have a problem. You still have time to correct your situation by covering the short and taking a position in the company. Its like turning a looser into a winner.

Good luck.

RMHB is the one stock to own for a very bright future.

As an investment you won't need a lot of shares to attain great wealth. The drug Leronlimab will make all who own it stock will attain great wealth.

You will need some money to invest, time and patience.

Its one thing to buy stock in a company you are an executive in but another to buy for you wife and child. The Chairman has done this and it tells me he knows a lot more then the public and that is my clue to load the boat.

"LERONLIMAB" IS THE GOLDEN WORD THAT WILL MAKE THE INVESTOR RICH BEYOND THEIR WILDEST DREAMS.

RMHB has now come into its own. The stock will continue to rise.

He is not going to cash out. He knows what is coming. He is setting up his family to accumulate great wealth.

I will keep buying in small amounts because I am 85 with very limited cash. I don't think you need many shares to make a lot of money in this company.

Leronlimab is a winner and the executives know it.

What got little attention was the fact that the Chairman loaded up on millions of shares for himself and a load for his wifw and child. That's confidence!

Its the reason I bought. Nobody knows more about the companies potential then the officers.

If you have the cash this is a better place to put it then a bank. Long term it a wealth maker.

SKDI is a growth stock by acquisition grab all you can afford and get rich.

SKDI is a monster puppy growing into a top dog. Buy hold abd get rich.

The big "IF".

If it was proven that Leronlimab is the cure all for the dreaded virus, Cancer, Hiv, etc then there is no limit to where the stock price will rise to.

There are many stumbling blocks ahead but I feel in time they will be overcome.

When? I have no idea. We are dealing with approval of the FDA, Politics, Big pharma losing their share of the drug market.

If you are young enough to wait out the outcome you will have a comfortable retirement.

You will need money to buy an investment in the stock, and above all unlimited patience.

SO BUY SOME SHARES WITH UNNEEDED CASH AND FORGET ABOUT IT FOR MANY MONTHS AND YEARS TO COME.

The obvious answer to limited capital is either a buyout or merger with a big drug company. With an Outstanding share count at about 507,458,680 as of 5/7/20 a buyout would need to be in the multi billions of dollars. Only a hugh drug company wouild be able to take the company over. It is more likely a joint venture would take place.

Good things are in the works. A treatment to control the virus and a way to restart the economy.

The future looks bright.

I intend to pick up some shares of CYDY and wait for the action to begin.

Just a 100 share buy would make the investors day.

This explains CYDY

Sun Kissed's Hakuna April Online Sales Surpass Expectations, Thousands of Units on Back-order for CBD Biometric Sensor Storage Device as Supply Sells-out

WOW! SMART INVESTORS ARE LOADING UP.

Thank you for your post.
Any company that attacks these dreaded diseases is more then welcome in my portfolio, just a tiny investment has the potential to increase my wealth many times over.

BUY SOME SHARES AND SIT ON THEM.

I believe its a mistake to sell TRNX short.There is something brewing and we are in the process of it being released.

Don't forget Taronis owns a big chunk of its spin off TRNF. They have the best known cutting gas in the world and TRNX has the best water purification system with paterns. I don't know what is about to be announced but I suspect its a marriage with a bigger company.
Wait for it, if I am right big bucks will happen soon.

Accept no substitute.